WHY INDOOR AIR CAN MAKE SYMPTOMS WORSE

THE CARCO STRESS MODEL: Carbon Monoxide Exposure → Peroxynitrite Formation in Capillaries → Fibrin Amyloid Formation → Microvascular Obstruction → Reduced Mitochondrial Oxygen Availability → Aerobic Energy Production Failure → Systemic Dysfunction

This page details how elevated indoor carbon dioxide increases acid load, activates pain receptors, and impairs physical recovery when tissue oxygen delivery is compromised.

Elevated Indoor CO2 Disrupts Energy Production

Carbon dioxide is commonly used as a building ventilation indicator. Elevated indoor carbon dioxide causes air hunger, headaches, sleepiness, and reduced concentration.

When microvascular oxygen availability is already restricted, additional carbon dioxide shifts cellular metabolism further into anaerobic energy production.

Carbon dioxide acts as an active chemical driver of tissue acidosis. When microvascular oxygen delivery is reduced, inhaled carbon dioxide increases tissue acidity, forces anaerobic glycolysis, accelerates fatigue, and causes pain.

Tissue Acidity Causes Muscle Pain and Heaviness

Carbon dioxide combines with water in blood and tissues to form carbonic acid, which dissociates into bicarbonate and hydrogen ions (H^+). Higher carbon dioxide concentrations directly increase proton density and lower local tissue pH.

When microcirculation is impaired, cells shift to glycolysis, generating additional metabolic acid. Adding inhaled carbon dioxide to this state lowers tissue pH further, causing muscle heaviness, burning and weakness.

Acidification and Pain Receptors

Increased carbon dioxide raises hydrogen ion concentration in peripheral tissues. When local pH drops below physiological thresholds, it activates acid-sensitive nociceptors and ion channels.

In metabolically compromised tissue, oxygen availability is unstable and proton clearance is impaired. This produces localized tissue acidosis and pain activation even when systemic arterial blood tests remain normal.

Impaired Microcirculation and Byproduct Clearance

Adequate capillary perfusion delivers oxygen and clears carbon dioxide and protons from tissues. Impaired microvascular perfusion disrupts both oxygen supply and byproduct clearance.

Oxygen deprivation increases intracellular proton production while slow capillary flow delays proton clearance. This delay maintains low tissue pH and prolongs pain receptor activation.

Elevated indoor CO₂ → increased CO₂ diffusion into blood and tissues → carbonic acid formation → increased H⁺ concentration → decreased tissue pH (acidification) → acid-sensing ion channel activation → altered cellular ion regulation → increased reliance on anaerobic glycolysis → increased lactate/H⁺ production → further acidification → impaired capillary perfusion and metabolite clearance → nociceptor activation → pain.

Delayed Post-Exertional Recovery

Physical exertion increases cellular energy demand and reliance on glycolysis in hypoxic tissues. Accumulating protons require prolonged oxidative clearance.

Additional indoor carbon dioxide exposure slows this clearance process. Tissues remain in a state of sustained acidosis, producing prolonged post-exertional symptom worsening.

Sustained Exposure and Cellular Recovery Failure

Prolonged exposure to elevated indoor carbon dioxide prevents tissues from completing metabolic recovery. Acid-base balance remains disrupted over consecutive hours or days.

This sustained tissue acidosis maintains local oxidative stress and cellular stress responses, preventing the metabolic system from returning to its baseline resting state.

Environmental Threshold Differences

Building ventilation standards are designed for healthy individuals. Standard guidelines classify 800–1000 ppm as acceptable indoor carbon dioxide.

For an individual with restricted microvascular oxygen delivery, 800–1000 ppm carbon dioxide adds an intolerable acid load. The exposure overwhelms reduced metabolic buffering capacity without requiring toxic levels of exposure.

When microvascular oxygen delivery is unstable, physiological reserve is minimal. Adding carbon dioxide triggers immediate metabolic shifts.

Recommended Indoor CO2 400-600 ppm

Model-based recommendation: The 400–600 ppm range presented here is not an established clinical guideline. It is a proposed precautionary range based on the physiological effects of elevated CO₂ and the CARCO model, particularly for individuals with impaired microvascular perfusion.

Outdoor carbon dioxide levels measure approximately 420 ppm. Indoor levels rise due to human respiration and inadequate ventilation.

When microvascular perfusion and aerobic energy metabolism are already impaired, additional CO₂ exposure may further increase physiological stress through CO₂-related changes in blood chemistry and circulation. Therefore, keeping indoor CO₂ as close to outdoor/background levels as reasonably possible may be preferable for susceptible individuals.

For individuals with impaired microvascular perfusion, indoor carbon dioxide should be maintained between 400 and 600 ppm. Concentrations above 800 ppm cause measurable physiological strain and trigger symptoms.

Indoor carbon dioxide levels should remain between 400 and 600 ppm to avoid worsening local tissue acidosis in oxygen-deprived tissues.

Sources